Table 2.

cTnI and cTnAAbs in patient groups at different sampling times.1

cTnI, μg/LcTnAAb assay signal, cps2
Group A (cTnI+/cTnAAb)Group B (cTnI+/cTnAAb+)Group B1 (first sample cTnAAb+)Group B2 (first sample cTnAAb)Group C (cTnI/cTnAAb)Group B1Group B2
n5314951495
Admission1.022 (0.263–2.406)4.842 (0.719–6.636)42.950 (0.188–5.336)6.912 (5.573–8.171)c,d0.007 (0.005–0.014)(1538–4628)<100 (<100–<100)3
1 week0.049 (0.015–0.129)1.179 (0.385–2.886)41.776 (0.015–3.098)40.845 (0.567–1.930)40.005 (0.005–0.014)12 162 (3101–2 2415)1174 (555–2097)3
3 months0.005 (0.005–0.006)0.011 (0.005–0.019)40.014 (0.005–0.025)40.007 (0.006–0.013)0.006 (0.005–0.008)12 479 (6465–53 061)3089 (2235–5707)3
12 months0.005 (0.005–0.007)0.008 (0.005–0.016)40.011 (0.007–0.041)40.005 (0.005–0.008)30.005 (0.005–0.007)7831 (3751–17 800)320 (<100–1101)3